Navigation
Suscribe
Menu Search Facebook Twitter
Search Close
Menu ALL SECTIONS
  • Capital Coahuila
  • Capital Hidalgo
  • Capital Jalisco
  • Capital Morelos
  • Capital Oaxaca
  • Capital Puebla
  • Capital Quintana Roo
  • Capital Querétaro
  • Capital Veracruz
  • Capital México
  • Capital Michoacán
  • Capital Mujer
  • Reporte Índigo
  • Estadio Deportes
  • The News
  • Efekto
  • Diario DF
  • Capital Edo. de Méx.
  • Green TV
  • Revista Cambio
Radio Capital
Pirata FM
Capital Máxima
Capital FM
Digital
Prensa
Radio
TV
X
Newsletter
Facebook Twitter
X Welcome! Subscribe to our newsletter and receive news, data, statistical and exclusive promotions for subscribers
World

Jury Awards $417M in Lawsuit Linking Talcum Powder to Cancer 

The lawsuit alleged Johnson & Johnson failed to adequately warn consumers about the potential cancer risks of talcum powder

Bottles of Johnson & Johnson branded baby powder, photo: Flickr
4 months ago

LOS ANGELES – A Los Angeles jury on Monday ordered Johnson & Johnson to pay $417 million to a woman who claimed in a lawsuit that the talc in its iconic baby powder causes ovarian cancer when applied regularly for feminine hygiene.

The lawsuit was brought by a California woman, Eva Echeverría, who alleged Johnson & Johnson failed to adequately warn consumers about the potential cancer risks of talcum powder.

Echeverría developed ovarian cancer as a “proximate result of the unreasonably dangerous and defective nature of talcum powder,” Echeverría said in her lawsuit.

Echeverría’s attorney, Mark Robinson, said his client hoped the verdict would lead Johnson & Johnson to include additional warnings on its products.

“Mrs. Echeverría is dying from this ovarian cancer and she said to me all she wanted to do was to help the other women throughout the whole country who have ovarian cancer for using Johnson & Johnson for 20 and 30 years,” Robinson said.

“She really didn’t want sympathy,” he added. “She just wanted to get a message out to help these other women.”


Johnson & Johnson spokeswoman Carol Goodrich said in a statement that the company will appeal the jury’s decision. She says while the company sympathizes with those impacted by ovarian cancer, she says science supports the safety of Johnson’s baby powder.

A St. Louis, Missouri jury in May awarded $110.5 million to a Virginia woman who was diagnosed with ovarian cancer in 2012.

She had blamed her illness on her use for more than 40 years of the company’s talcum powder-containing products.

Besides that case, three other jury trials in St. Louis reached similar outcomes last year — issuing awards of $72 million, $70.1 million and $55 million, for a combined total of $307.6 million.

Goodrich said the company is preparing for additional trials in the U.S. and will continue to defend the product’s safety.

MICHAEL BALSAMO

Comments Whatsapp Twitter Facebook Share
More From The News
Latest News

Democrat Jones wins stunning red-state A ...

2 days ago
Business

Asian stocks mixed ahead of Fed rate ann ...

2 days ago
Entertainment

NFL Network suspends analysts over sexua ...

3 days ago
Science

SpaceX delivery delayed few days; 1st re ...

3 days ago
Most Popular

French PM says Disputed Labour Bill Open ...

By The Associated Press
Business

Business Leaders Bullish About Long Term ...

By Lázaro González
Business

New Delivery App Rappi Says It's Not Sel ...

By Caitlin Donohue
Business

Power Lunch to Close

By The Associated Press
Business

Daily Exchange: Dollar Continues Descent ...

By Notimex
Business